M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Ajinomoto Group Acquires All Shares of GeneDesign, Inc., a Nucleic Acid Drug CDMO.To Accelerate Expansion of the Contract Business for Oligonucleotides.Using GeneDesign's Management Resources
TOKYO - Ajinomoto Co., Inc. ("Ajinomoto Co.") and its consolidated subsidiary S.A. Ajinomoto OmniChem N.V. ("OmniChem") agreed to acquire all the issued and outstanding shares of GeneDesign, Inc., a major Japanese contract development and manufacturing organization (CDMO1) for...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search